UnitedHealth Group Incorporated UNH NYSE

UnitedHealth Group Incorporated (UNH) reported total assets of $309.58B and total liabilities of $207.88B for fiscal year 2025, resulting in total equity of $101.7B.

The company held $28.12B in cash and short-term investments. Total debt stood at $78.39B, with net debt of $54.02B. The Debt-to-Equity (D/E) ratio was 0.77 (moderate).

Current ratio is 0.79, which may signal tight short-term liquidity. Interest coverage is 4.7x (adequate).

Criteria supported by this page:

• HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (51/100) — Total assets $309.58B and equity $101.7B support the company's competitive scale
• VALUE (66/100) — Debt-to-Equity 0.77 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.

AZN

AstraZeneca PLC

$204.38

+1.06%

MRK

Merck & Co., Inc.

$119.96

-0.16%

NVS

Novartis AG

$153.38

-0.71%

TMO

Thermo Fisher Scientific Inc.

$527.22

+2.53%

ABT

Abbott Laboratories

$101.07

+0.38%

NVO

Novo Nordisk A/S

$39.32

+3.53%

CVS

CVS Health Corporation

$77.62

-0.60%

CI

Cigna Corporation

$272.60

-0.92%